Patents by Inventor Mark Gutniak

Mark Gutniak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a peptide
    Publication number: 20070225212
    Abstract: The invention employs GLP-1 (7-37), GLP-1(7-36)amide, and certain related compounds in combination with an oral hypoglycaemic agent for treating diabetes mellitus.
    Type: Application
    Filed: March 19, 2007
    Publication date: September 27, 2007
    Inventors: Suad Efendic, Mark Gutniak, Ole Kirk
  • Use of a peptide
    Publication number: 20060247174
    Abstract: The invention employs GLP-1 (7-37), GLP-1(7-36)amide, and certain related compounds in combination with an oral hypoglycaemic agent for treating diabetes mellitus.
    Type: Application
    Filed: July 13, 2006
    Publication date: November 2, 2006
    Inventors: Suad Efendic, Mark Gutniak, Ole Kirk
  • Use of a peptide
    Publication number: 20030083259
    Abstract: The invention employs GLP-1 (7-37), GLP-1(7-36)amide, and certain related compounds in combination with an oral hypoglycaemic agent for treating diabetes mellitus.
    Type: Application
    Filed: August 22, 2002
    Publication date: May 1, 2003
    Inventors: Suad Efendic, Mark Gutniak, Ole Kirk
  • Use of a peptide
    Publication number: 20010002394
    Abstract: GLP-1(7-37), GLP-1(7-36)amide, and certain related compounds can be used to provide a medicament for use in the treatment of diabetes in a regimen which additionally comprises treatment with an oral hypoglycaemic agent. A strong synergistic effect is observed.
    Type: Application
    Filed: January 4, 2001
    Publication date: May 31, 2001
    Inventors: Suad Efendic, Mark Gutniak, Ole Kirk
  • Use of a peptide
    Patent number: 5631224
    Abstract: The invention employs GLP-1(7-37), GLP-1(7-36)amide, and certain related compounds in combination with an oral hypoglycaemic agent for treating diabetes mellitus.
    Type: Grant
    Filed: October 13, 1994
    Date of Patent: May 20, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Suad Efendic, Mark Gutniak, Ole Kirk
  • Peptide
    Patent number: RE37302
    Abstract: The invention employs GLP-1(7-37), GLP-1(7-36)amide, and certain related compounds in combination with an oral hypoglycaemic agent for treating diabetes mellitus.
    Type: Grant
    Filed: February 19, 1998
    Date of Patent: July 31, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Suad Efendic, Mark Gutniak, Ole Kirk